Trademark Information

Application ID
Status
Date of Application
28 October 2021
Classes
5
Proprietor
Strides House, Bilekhalli, Bannerghatta Road, Bangalore 560076
Attorney
Altacit Global[19406]
Shed No. C2 A, Thiru Vi Ka Industrial Estate, Guindy, Chennai 600 032.
Type
Word
State
Karnataka
Country
Filing Mode
e-Filing
IP Office
CHENNAI
Used Since
Valid / Upto
Description
[Class : 5] Pharmaceutical And Medicinal Preparations

Documents

Examination Report

Uploaded Documents

1 TM-A(TRADE MARKS APPLICATION) 28 Oct 2021
2 Reply to Exam Report (MIS-R) 07 Jan 2022
3 Authorization Letter 10 Jan 2023
4 Documents in support of Show cause Hearing (SCH) 13 Jan 2023
5 Journal Copy 16 Nov 2023
6 TM-O(NOTICE OF OPPOSITION) 13 Dec 2023
7 Annexure -1 under rule 46 10 Jun 2024
7 Evidence Affidavit Under Rule 46 (TOP) 10 Jun 2024
8 Annexure -1 under rule 46 10 Jun 2024
8 Evidence Affidavit Under Rule 46 (TOP) 10 Jun 2024

Correspondence and Notices

1 EXAMINATION REPORT 12640878   14 Dec 2021
2 Hearing Notice (Show Cause) 14451363   08 Dec 2022
3 Tribunal Accepted Notice for : 5191192 15750495 6093460 02 Aug 2023
4 Opposition Notice 16821937 6391174 14 Dec 2023
5 Opposition Counter Statement 17383549 6544637 12 Feb 2024

Frequently Asked Questions

What is the application date as per IP India website?

As per IP India data the trademark was applied on 28 October 2021.

Who has filed the trademark application with the TMO?

STRIDES PHARMA SCIENCE applied for Striglimy m1 sr.

What is the listed class of the Striglimy m1 sr with IP India?

Listed class of trademark Striglimy m1 sr is 5.

As per IP india what is the stage of trademark application?

Striglimy m1 sr is on the Opposed stage of the trademark process.

What is the Serial number provided by the trademark data?

Serial Number provided to trademark application is 5191192

Who filed the trademark on behalf of the proprietor?

Trademark application was filed by the following attorney agent:
Altacit Global

How is the Striglimy m1 sr categorized?

The trademark is categorized as WORD.